Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  SOFINNOVA VENTURE PARTNERS VI L P
2. Date of Event Requiring Statement (Month/Day/Year)
02/23/2010
3. Issuer Name and Ticker or Trading Symbol
Anthera Pharmaceuticals Inc [ANTH]
(Last)
(First)
(Middle)
140 GEARY STREET, 10TH FLOOR
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN FRANCISCO, CA 94108
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A-2 Convertible Preferred Stock   (1)   (1) Common Stock 384,175 $ (2) D (3)  
Series B-1 Convertible Preferred Stock   (4)   (4) Common Stock 828,323 $ (2) D (3)  
Series B-2 Convertibe Preferred Stock   (5)   (5) Common Stock 864,855 $ (2) D (3)  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
SOFINNOVA VENTURE PARTNERS VI L P
140 GEARY STREET, 10TH FLOOR
SAN FRANCISCO, CA 94108
    X    
Sofinnova Management VI, L.L.C.
140 GEARY ST 10TH FL
SAN FRANCISCO, CA 94108
    X    

Signatures

SOFINNOVA VENTURE PARTNERS VI, L.P., a Delaware Limited Partnership By: Sofinnova Management VI, L.L.C., a Delaware limited liability company, Its: General Partner /s/ Nathalie Auber Nathalie Auber, Attorney-in-Fact 02/23/2010
**Signature of Reporting Person Date

Nathalie Auber, Attorney-in-Fact 02/23/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Series A-2 Convertible Preferred Stock is convertible on a one-for-one basis at any time at the holder's election and has no expiration date.
(2) Not applicable.
(3) Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV VI LLC") is the general partner of SV VI, and James I. Healy, a director of the issuer, Michael F. Powell, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI. Such persons and entities disclaim beneficial ownership of shares held by SV VI except to the extent of any pecuniary interest therein.
(4) The Series B-1 Convertible Preferred Stock is convertible on a one-for-one basis at any time at the holder's election and has no expiration date.
(5) The Series B-2 Convertible Preferred Stock is convertible on a one-for-one basis at any time at the holder's election and has no expiration date.
 
Remarks:
Exhibit List
   Exhibit 24.1 - Power of Attorney

/s/ Nathalie Auber
Nathalie Auber, Attorney-in-Fact
for James I. Healy, M.D., Ph.D.

/s/ Nathalie Auber
Nathalie Auber, Attorney-in-Fact
for Michael F. Powell


/s/ Nathalie Auber
Nathalie Auber, Attorney-in-Fact
for Alain L. Azan

/s/ Nathalie Auber
Nathalie Auber, Attorney-in-Fact
for Eric P. Buatois

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.